Sagimet Biosciences Inc. (SGMT) stock
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.22−0.71 (-6.50%)
Close on Nov 13, 2026Market cap $635.26MP/E –Yield –
Sagimet Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sagimet Biosciences's enterprise value was $172.17M on Nov 11, 2026, against $107.62M a year earlier. Over the last 2 years it ranged from -$56.50M to $172.17M, with a median of $100.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $172.17M | +162.3% |
| 2025 | Dec 31, 2025 | $65.64M | – |
| 2023 | Oct 31, 2023 | -$17.73M | – |
See a number that looks wrong?